Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series
Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1514428/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591684302536704 |
|---|---|
| author | Maris Taube Maris Taube Alise Alma Lesiņa |
| author_facet | Maris Taube Maris Taube Alise Alma Lesiņa |
| author_sort | Maris Taube |
| collection | DOAJ |
| description | Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms. |
| format | Article |
| id | doaj-art-27fa7973a72247e7b14525ab14f38271 |
| institution | Kabale University |
| issn | 1664-0640 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychiatry |
| spelling | doaj-art-27fa7973a72247e7b14525ab14f382712025-01-22T07:11:31ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402025-01-011510.3389/fpsyt.2024.15144281514428Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case seriesMaris Taube0Maris Taube1Alise Alma Lesiņa2Department of Psychosomatic Medicine and Psychotherapy, Riga Stradiņš University, Riga, LatviaDepartment of Depression and Crisis, National Centre of Mental Health, Riga, LatviaFaculty of Medicine, Riga Stradiņš University, Riga, LatviaSevere acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1514428/fullCOVID-19 vaccinesSARS-CoV-2 vaccineBioNTech162 vaccineanxietycase reports |
| spellingShingle | Maris Taube Maris Taube Alise Alma Lesiņa Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series Frontiers in Psychiatry COVID-19 vaccines SARS-CoV-2 vaccine BioNTech162 vaccine anxiety case reports |
| title | Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series |
| title_full | Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series |
| title_fullStr | Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series |
| title_full_unstemmed | Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series |
| title_short | Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series |
| title_sort | case report development of anxiety symptoms after receiving the pfizer biontech bnt162b2 covid 19 vaccine a case series |
| topic | COVID-19 vaccines SARS-CoV-2 vaccine BioNTech162 vaccine anxiety case reports |
| url | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1514428/full |
| work_keys_str_mv | AT maristaube casereportdevelopmentofanxietysymptomsafterreceivingthepfizerbiontechbnt162b2covid19vaccineacaseseries AT maristaube casereportdevelopmentofanxietysymptomsafterreceivingthepfizerbiontechbnt162b2covid19vaccineacaseseries AT alisealmalesina casereportdevelopmentofanxietysymptomsafterreceivingthepfizerbiontechbnt162b2covid19vaccineacaseseries |